Patents by Inventor Nathan D. Heiking

Nathan D. Heiking has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220241440
    Abstract: A lighting device configured to deactivate pathogens in an environment. The lighting device includes a housing, means for mounting the housing to a surface in the environment, one or more first light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a first range of wavelengths, and one or more second light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a second range of wavelengths different from the first range of wavelengths. The disinfecting light produced by the first light-emitting elements and the disinfecting light produced by the second light-emitting elements mix to form a combined light, the combined light being visible light other than white light.
    Type: Application
    Filed: April 22, 2022
    Publication date: August 4, 2022
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Patent number: 11324843
    Abstract: A lighting device configured to deactivate pathogens in an environment. The lighting device includes a housing, means for mounting the housing to a surface in the environment, one or more first light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a first range of wavelengths, and one or more second light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a second range of wavelengths different from the first range of wavelengths. The disinfecting light produced by the first light-emitting elements and the disinfecting light produced by the second light-emitting elements mix to form a combined light, the combined light being visible light other than white light.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: May 10, 2022
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Patent number: 11054110
    Abstract: A lighting device configured to deactivate dangerous microorganisms in an environment. The lighting device includes at least one lighting element with a single light source configured to provide disinfecting light. At least a first component of the light has a wavelength of about 405 nm, and at least a second component of the light has a wavelength of greater than 500 nm. The first component of light has a minimum integrated irradiance of 0.01 mW/cm2 measured from any unshielded point in the environment that is 1.5 m from any point on any external-most luminous surface of the lighting device.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: July 6, 2021
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking
  • Patent number: 11054109
    Abstract: A lighting device configured to deactivate dangerous pathogens (e.g., MRSA bacteria) in an environment. The lighting device includes at least one lighting element with a single light source configured to provide light. At least a first component of the light comprising light having a wavelength of about 405 nm, and at least a second component of the light comprising light having a wavelength of greater than 420 nm. The first component of light has a minimum integrated irradiance of 0.01 mW/cm2 measured from any unshielded point in the environment that is 1.5 m from any point on any external-most luminous surface of the lighting device.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: July 6, 2021
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking
  • Patent number: 10823369
    Abstract: A lighting device configured to deactivate pathogens in an environment. The lighting device includes at least one first light-emitting element configured to emit light having a wavelength of between 400 nm and 420 nm, wherein the light emitted by the at least one first light-emitting element is configured to deactivate the pathogens in the environment. The lighting device also includes at least one second light-emitting element configured to emit light having a wavelength of greater than 420 nm. A first combined light output of the light emitted by the at least one first and the at least one second light-emitting elements includes visible light that is perceived as white light. The white light has properties that make it visually appealing and unobjectionable.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: November 3, 2020
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: Patrick J. Marry, Nathan D. Heiking, Keith H. Dykstra
  • Patent number: 10765765
    Abstract: Methods and lighting systems to deactivating deactivate MRSA bacteria in a volumetric space over a period of time. At least one lighting element of each of one or more lighting fixtures provide light. The light includes a first disinfecting light having a wavelength of about 405 nm and a minimum integrated irradiance of 0.01 mW/cm2, and a second component having a wavelength of greater than 420 nm. The one or more lighting elements of the one or more lighting fixtures apply a determined total radiometric power to produce a desired power density measured at any exposed surface within the volumetric space during the period of time. The minimum power density includes a minimum integrated irradiance of the disinfecting light equal to 0.01 mW/cm2.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: September 8, 2020
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking
  • Patent number: 10617775
    Abstract: A lighting device configured to deactivate MRSA bacteria in air in an environment, including a housing; a light-emitting diode (LED) configured to emit light having a wavelength of about 470 nm; a light converting phosphor coating; wherein a first component of the light emitted by the LED travels through the light converting phosphor coating without alteration, and a second component of light emitted by the LED is converted by the converting phosphor coating into light having a wavelength of greater than 500 nm; wherein the first component of the light has a minimum integrated irradiance of 0.01 mW/cm2; wherein the first component of the light emitted by the LED and the second component of light emitted by the LED mix to form a combined light, with the combined light being visible light; and means for directing the combined visible light to the air in the environment.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: April 14, 2020
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Publication number: 20190358353
    Abstract: A lighting device configured to deactivate pathogens in an environment. The lighting device includes a housing, means for mounting the housing to a surface in the environment, one or more first light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a first range of wavelengths, and one or more second light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a second range of wavelengths different from the first range of wavelengths. The disinfecting light produced by the first light-emitting elements and the disinfecting light produced by the second light-emitting elements mix to form a combined light, the combined light being visible light other than white light.
    Type: Application
    Filed: August 12, 2019
    Publication date: November 28, 2019
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Patent number: 10456485
    Abstract: A lighting device configured to deactivate dangerous pathogens (e.g., MRSA bacteria) in an environment. The lighting device includes at least one lighting element with a single light source configured to provide light. At least a first component of the light comprising light having a wavelength of about 405 nm, and at least a second component of the light comprising light having a wavelength of greater than 420 nm. The first component of light has a minimum integrated irradiance of 0.01 mW/cm2 measured from any unshielded point in the environment that is 1.5 m from any point on any external-most luminous surface of the lighting device.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: October 29, 2019
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking
  • Patent number: 10434202
    Abstract: A lighting device configured to deactivate pathogens in an environment. The lighting device includes a housing, means for mounting the housing to a surface in the environment, one or more first light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a first range of wavelengths, and one or more second light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a second range of wavelengths different from the first range of wavelengths. The disinfecting light produced by the first light-emitting elements and the disinfecting light produced by the second light-emitting elements mix to form a combined light, the combined light being visible light other than white light.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: October 8, 2019
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Patent number: 10363325
    Abstract: A lighting system configured to provide light and disinfect air in an environment. The lighting system includes an HVAC unit configured to provide air to the environment, and a lighting device configured to deactivate microorganisms in the air. The lighting device includes a housing, means for mounting the housing to a surface in the environment, one or more first light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a first range of wavelengths, and one or more second light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a second range of wavelengths different from the first range of wavelengths. The disinfecting light produced by the first light-emitting elements and the disinfecting light produced by the second light-emitting elements mix to form a combined light, the combined light being visible light other than white light.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: July 30, 2019
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Publication number: 20190224350
    Abstract: A lighting device configured to deactivate pathogens in an environment. The lighting device includes at least one first light-emitting element configured to emit light having a wavelength of between 400 nm and 420 nm, wherein the light emitted by the at least one first light-emitting element is configured to deactivate the pathogens in the environment. The lighting device also includes at least one second light-emitting element configured to emit light having a wavelength of greater than 420 nm. A first combined light output of the light emitted by the at least one first and the at least one second light-emitting elements includes visible light that is perceived as white light. The white light has properties that make it visually appealing and unobjectionable.
    Type: Application
    Filed: March 28, 2019
    Publication date: July 25, 2019
    Inventors: Patrick J. Marry, Nathan D. Heiking, Keith H. Dykstra
  • Publication number: 20190083667
    Abstract: A lighting device configured to deactivate MRSA bacteria in air in an environment, including a housing; a light-emitting diode (LED) configured to emit light having a wavelength of about 470 nm; a light converting phosphor coating; wherein a first component of the light emitted by the LED travels through the light converting phosphor coating without alteration, and a second component of light emitted by the LED is converted by the converting phosphor coating into light having a wavelength of greater than 500 nm; wherein the first component of the light has a minimum integrated irradiance of 0.01 mW/cm2; wherein the first component of the light emitted by the LED and the second component of light emitted by the LED mix to form a combined light, with the combined light being visible light; and means for directing the combined visible light to the air in the environment.
    Type: Application
    Filed: October 16, 2018
    Publication date: March 21, 2019
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Publication number: 20180326104
    Abstract: A lighting device configured to deactivate pathogens in an environment. The lighting device includes a housing, means for mounting the housing to a surface in the environment, one or more first light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a first range of wavelengths, and one or more second light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a second range of wavelengths different from the first range of wavelengths. The disinfecting light produced by the first light-emitting elements and the disinfecting light produced by the second light-emitting elements mix to form a combined light, the combined light being visible light other than white light.
    Type: Application
    Filed: July 3, 2018
    Publication date: November 15, 2018
    Applicant: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Publication number: 20180311387
    Abstract: A lighting device configured to deactivate dangerous microorganisms in an environment. The lighting device includes at least one lighting element with a single light source configured to provide disinfecting light. At least a first component of the light has a wavelength of about 405 nm, and at least a second component of the light has a wavelength of greater than 500 nm. The first component of light has a minimum integrated irradiance of 0.01 mW/cm2 measured from any unshielded point in the environment that is 1.5 m from any point on any external-most luminous surface of the lighting device.
    Type: Application
    Filed: July 5, 2018
    Publication date: November 1, 2018
    Inventors: James W. Hawkins, Nathan D. Heiking
  • Publication number: 20180311386
    Abstract: A lighting system configured to provide light and disinfect air in an environment. The lighting system includes an HVAC unit configured to provide air to the environment, and a lighting device configured to deactivate microorganisms in the air. The lighting device includes a housing, means for mounting the housing to a surface in the environment, one or more first light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a first range of wavelengths, and one or more second light-emitting elements arranged in the housing and configured to each produce disinfecting light having a wavelength in a second range of wavelengths different from the first range of wavelengths. The disinfecting light produced by the first light-emitting elements and the disinfecting light produced by the second light-emitting elements mix to form a combined light, the combined light being visible light other than white light.
    Type: Application
    Filed: July 3, 2018
    Publication date: November 1, 2018
    Applicant: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking, Patrick J. Marry
  • Publication number: 20180243453
    Abstract: Methods and lighting systems to deactivating deactivate MRSA bacteria in a volumetric space over a period of time. At least one lighting element of each of one or more lighting fixtures provide light. The light includes a first disinfecting light having a wavelength of about 405 nm and a minimum integrated irradiance of 0.01 mW/cm2, and a second component having a wavelength of greater than 420 nm. The one or more lighting elements of the one or more lighting fixtures apply a determined total radiometric power to produce a desired power density measured at any exposed surface within the volumetric space during the period of time. The minimum power density includes a minimum integrated irradiance of the disinfecting light equal to 0.01 mW/cm2.
    Type: Application
    Filed: April 27, 2018
    Publication date: August 30, 2018
    Inventors: James W. Hawkins, Nathan D. Heiking
  • Publication number: 20180243452
    Abstract: A lighting device configured to deactivate dangerous pathogens (e.g., MRSA bacteria) in an environment. The lighting device includes at least one lighting element with a single light source configured to provide light. At least a first component of the light comprising light having a wavelength of about 405 nm, and at least a second component of the light comprising light having a wavelength of greater than 420 nm. The first component of light has a minimum integrated irradiance of 0.01 mW/cm2 measured from any unshielded point in the environment that is 1.5 m from any point on any external-most luminous surface of the lighting device.
    Type: Application
    Filed: April 27, 2018
    Publication date: August 30, 2018
    Inventors: James W. Hawkins, Nathan D. Heiking
  • Patent number: 9700641
    Abstract: A lighting device configured to deactivate dangerous pathogens (e.g., MRSA bacteria) in an environment. The lighting device includes at least one lighting element configured to provide light. At least a first component of the light comprising light having a wavelength of between 400 nm and 420 nm, and at least a second component of the light comprising light having a wavelength of greater than 420 nm. The first component of light has a minimum integrated irradiance of 0.05 mW/cm2 measured from any unshielded point in the environment that is 1.5 m from any point on any external-most luminous surface of the lighting device.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: July 11, 2017
    Assignee: KENALL MANUFACTURING COMPANY
    Inventors: James W. Hawkins, Nathan D. Heiking
  • Publication number: 20160375162
    Abstract: A lighting device configured to deactivate pathogens in an environment. The lighting device includes at least one first light-emitting element configured to emit light having a wavelength of between 400 nm and 420 nm, wherein the light emitted by the at least one first light-emitting element is configured to deactivate the pathogens in the environment. The lighting device also includes at least one second light-emitting element configured to emit light having a wavelength of greater than 420 nm. A first combined light output of the light emitted by the at least one first and the at least one second light-emitting elements includes visible light that is perceived as white light. The white light has properties that make it visually appealing and unobjectionable.
    Type: Application
    Filed: June 9, 2016
    Publication date: December 29, 2016
    Applicant: KENALL MANUFACTURING COMPANY
    Inventors: Patrick J. Marry, Nathan D. Heiking, Keith H. Dykstra